Research study Program year 2019 Source: CMS Open Payments

Dasotraline Binge Eating Disorder Extension Study

ClinicalTrials.gov NCT02684279

Research payments

$2,003,581

652 payments

Through program year 2019, $2,003,581 in research payments was reported against Dasotraline Binge Eating Disorder Extension Study, across 652 payments, paid by Sunovion Pharmaceuticals Inc..

Paid by: Sunovion Pharmaceuticals Inc.
ClinicalTrials.gov: NCT02684279

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$2,003,581	652

Breakdown

Who paid Research payments · program year 2019

Sunovion Pharmaceuticals Inc. $2,003,581 652 payments

Who received the money Research payments · program year 2019

Oregon Center For Clinical Investigations INC Organisation paid for research $155,175 54 payments
The Medical Research Network LLC Organisation paid for research $118,150 24 payments
Capstone Clinical Research INC Organisation paid for research $118,032 22 payments
Interspond Llc Organisation paid for research $113,473 30 payments
Pharmacology Research Institute Organisation paid for research $110,176 28 payments
Clinical Neuroscience Solutions INC Organisation paid for research $103,116 22 payments
Adams Clinical LLC Organisation paid for research $98,309 16 payments
Wake Research Associates LLC Organisation paid for research $97,844 8 payments
Texas Center For Drug Development INC Organisation paid for research $88,645 10 payments
Center for Emotional Fitness Organisation paid for research $83,334 24 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.